Unitary Patent System

A comprehensive analysis of Unitary Patents 2023-2024

Original price was: $501.03.Current price is: $100.20.

Whats in the Report – Introduction

 

The European Patent Convention (EPC) has established a unified procedure for patent grants across Europe, aiming to create a
consistent body of patent law that offers enhanced protection for inventions at a reduced cost. Under the EPC, patents can be centrally granted and opposed through the European Patent Office (EPO) for 39 contracting states, including EU and non-EU members. Upon grant, a European patent divides into national patents, each requiring individual validation and renewal fees. These national patents are enforceable independently within their respective jurisdictions, necessitating separate litigation and compliance with national laws for each.

Description

This research report provides a comprehensive analysis of unitary patent filings, registrations, and court decision trends, with a particular focus on the pharmaceutical and biotechnology sectors. The study aims to highlight key trends, identify top applicants, and categorize the most relevant International Patent Classifications (IPCs) in these fields. The analysis utilizes data from the European Patent Office (EPO) and various legal databases. It covers unitary patent filings and registrations from the inception of the unitary patent system to the present. The data is segmented by year, applicant, and IPC codes. Additionally, court decision trends are examined to provide insights into the legal landscape surrounding these patents. The report also sheds light on how has been the participation of pharmaceutical companies in the unitary patent system and what the future holds for these industries.